Stroke Quality Metrics
Stroke Quality Metrics
Our stroke volume and outcomes data is publicly reported according to Comprehensive Stroke Center requirements.
Stroke Volumes
Grady has one of the highest stroke and treatment volumes in the country, treating over 2200 patients in 2018 with the volume continuing to increase.
Stroke Treatment Rates
In 2020, Grady Hospital administered the clot-busting drug Activase in 23.7% of stroke cases – more than one and a half the national average. Our team also performed endovascular treatment (clot retrieval) in 27% of stroke cases – over four times the national average. Stroke patients are more than two times more likely to receive lifesaving intervention at Grady compared to other hospitals in the United States.
Ischemic Stroke Treatment Volumes
This shows the number of patients who received the clot-busting drug Activase IV and/or had endovascular clot retrieval at Grady Hospital or Activase IV at an outside hospital before being transferred to Grady for a higher level of care.
Ischemic Stroke Reperfusion
Reperfusion means restoring circulation to a part of the brain that was blocked by a blood clot in the artery. Grady stroke experts opened blocked arteries using endovascular thrombectomy 98.6% of the time! That is more than 10% above both average regional or national rates.
Nonsurgical Complication Rates
Grady not only treats more strokes, but our patients experience fewer complications — less than half as often as the regional or national averages.
Source: American Heart Association /American Stroke Association Get with the Guidelines data, January 2017-December 2020
Nationally Recognized Care
In 2020, Grady Hospital achieved the highest recognition for quality and speed, the American Heart Association/American Stroke Association, Get With The Guidelines® ‒ Stroke Gold Plus, Target Stroke Honor Roll Elite Plus. This award recognizes facilities that maintain an 85% or higher performance rate for quality indicators (measures used to gage stroke care performance) for two or more years, and achieve arrival to Activase administration times of ≤ 60 minutes in 75% and within 45 minutes in 50% of applicable acute ischemic stroke patients.